Connect with us

Business

Analysts predict Moderna to meet COVID-19 forecast for 2023

Published

on

Moderna is expected to achieve the lower end of its sales target for this year as it only needs to cater to a small section of the private market with its COVID-19 vaccine to attain that goal, as per the industry experts. 

According to four analysts who spoke with Reuters, it is possible for Moderna to achieve $2 billion in sales from the private market in 2023 if about 20 million people are vaccinated with its updated COVID-19 vaccine.

The company has said it expects total US COVID-19 vaccine demand to be as much as 100 million doses in the fall season.

Moderna predicts $6-8 billion in COVID-19 vaccine sales in 2023, with $2-4 billion coming from the commercial market. Pfizer’s full-year outlook for COVID-19 vaccine sales was lowered by about $2 billion due to lower-than-expected vaccination rates.

Moderna’s shares have fallen by some 22% since its larger rival’s warning.

“It is unlikely Moderna will have a negative fall (in its sales outlook) like Pfizer because they started off much more conservative,” said Oppenheimer & Co analyst Hartaj Singh.

Michael Yee, an analyst from Jefferies, said that while the rollout of the new shots was initially slow, it seems to be picking up, citing recent data. Yee expects most of the demand to come from people aged 65 and over.

Moderna reports third-quarter results on Thursday, two days after Pfizer posted its first quarterly loss since 2019 due to a large charge to account for the US government returning millions of doses of its COVID-19 antiviral treatment Paxlovid, as well as an inventory of its COVID-19 vaccine Comirnaty.

Moderna, a Cambridge, Massachusetts-based company, has seen its research and development (R&D) costs increase by 62% to $1.1 billion in Q2 2021, despite the COVID-19 vaccine being its only marketed product, as it aims to introduce other products.

The company’s RSV vaccine, which it aims to launch in the US in 2024, was found to be 82.4% effective in older adults with three or more symptoms in a late-stage trial. It would compete with recently approved vaccines from Pfizer and GSK.

Data from a late-stage study of Moderna’s flu vaccine with an updated formulation released in September showed it generated a stronger immune response against all four A and B strains of the influenza virus compared to traditional flu shots.

Moderna’s broader mRNA-based respiratory pipeline, which includes RSV and flu vaccines, is expected to reach $10 billion to $12 billion in sales, which will reduce expenses and bring R&D stability by 2025, Yee said.

Business

Islamic Sukuk Bonds: Government Is Expected To Begin Bond Auction Next Week

Published

on

By

There is now more positive economic news for the people of Pakistan. The government is anticipated to begin the Sukuk Islamic Bond auction next week, after the central bank’s announcement of a large drop in the policy rate.

Continue Reading

Business

SIFC Encourages Green Tourism: Reforming Visas to Increase Investment

Published

on

By

Enhancing investment in the tourism sector, Green Tourism Pakistan’s initiative has received backing from the Special Investment Facilitation Council.

Visa-On-Arrival for 126 countries, Visa-Free Entry for Gulf Cooperation Council nations, and 24-hour expedited visa processing are some of the main features of the Green Tourism Visa Policy.

It is anticipated that these endeavors will draw in about 80 million dollars in foreign direct investment and 8.3 billion rupees in domestic investment.

Green Tourism Private Limited has introduced hunting resorts in Naltar, Hunza, and Skardu, along with four- and five-star city hotels, to improve the tourism experience.

In the first phase of the project, 17 of the 78 areas have seen the start of development activity.

Approved is a central authority for Green Tourism that will supervise the growth of Air Operations.

To promote Religious Tourism, extra precautions have been taken to guarantee the security of visitors from all religions, including Sikhs and Buddhists.

Furthermore, in order to improve the quality of the tourist experience, the green guide quality program has been introduced to supply top-notch tour guides.

There is now a deluxe bus excursion from Islamabad to Peshawar that promotes local culture.

Continue Reading

Business

July 2024 export data from Pakistan shows a significant rise.

Published

on

By

The Strategic Investment Facilitation Council (SIFC) has been instrumental in improving Pakistani products’ access to international markets, as seen by the significant surge in exports from the country at the start of the 2024–25 fiscal year.

With a 7.26% rise over the same month the previous year, July 2024 exports to the US were $476.017 million. After increasing by 7.74% annually, the United Arab Emirates emerged as the second-largest export destination.

The third and fourth places were occupied by exports to the UK ($183.303 million) and China ($60.100 million). A substantial increase in exports to Afghanistan was recorded in July of this year, rising from $46.262 million to $88.065 million, largely due to successful anti-smuggling efforts.

With a combined export volume of $553.951 million, more important export destinations included Germany, the Netherlands, Italy, Spain, Saudi Arabia, and Turkey.

A bright future for the national economy is suggested by the growing confidence major international markets have in Pakistani exports. Through the efforts of SIFC and the government, this greater access to global markets has been made possible.

Pakistan’s economy is predicted to remain stable as a result of the export growth that SIFC has enabled.

Continue Reading

Trending